Canada - French - Health Canada

vifor fresenius medical care renal pharma ltd - patiromère (patiromère sorbitex calcique) - poudre pour suspension - 8.4g - patiromère (patiromère sorbitex calcique) 8.4g - potassium-removing agents

Canada - French - Health Canada

vifor fresenius medical care renal pharma ltd - patiromère (patiromère sorbitex calcique) - poudre pour suspension - 16.8g - patiromère (patiromère sorbitex calcique) 16.8g - potassium-removing agents

Canada - French - Health Canada

vifor fresenius medical care renal pharma ltd - patiromère (patiromère sorbitex calcique) - poudre pour suspension - 25.2g - patiromère (patiromère sorbitex calcique) 25.2g - potassium-removing agents

Belgium - French - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo sa-nv - itraconazole 100 mg - gélule - 100 mg - itraconazole 100 mg - itraconazole

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - candesartanum cilexetilum, amlodipinum - capsules - candesartanum cilexetilum 8 mg, amlodipinum 5 mg ut amlodipini besilas, lactosum monohydricum 101.95 mg, maydis amylum, carmellosum calcicum, macrogolum 8000, hydroxypropylcellulosum, magnesii stearas, kapselhülle: e 104, e 172 (flavum), e 171, gelatina, pro capsula. - essentielle hypertonie - synthetika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - candesartanum cilexetilum, amlodipinum - capsules - candesartanum cilexetilum 16 mg, amlodipinum 5 mg ut amlodipini besilas, lactosum monohydricum 203.9 mg, maydis amylum, carmellosum calcicum, macrogolum 8000, hydroxypropylcellulosum, magnesii stearas, kapselhülle: e 104, e 171, gelatina, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. - essentielle hypertonie - synthetika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - candesartanum cilexetilum, amlodipinum - capsules - candesartanum cilexetilum 8 mg, amlodipinum 10 mg ut amlodipini besilas, lactosum monohydricum 211.9 mg, maydis amylum, carmellosum calcicum, macrogolum 8000, hydroxypropylcellulosum, magnesii stearas, kapselhülle: e 104, e 172 (flavum), e 171, gelatina, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. - essentielle hypertonie - synthetika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - candesartanum cilexetilum, amlodipinum - capsules - candesartanum cilexetilum 16 mg, amlodipinum 10 mg ut amlodipini besilas, lactosum monohydricum 203.9 mg, maydis amylum, carmellosum calcicum, macrogolum 8000, hydroxypropylcellulosum, magnesii stearas, kapselhülle: e 171, gelatina, pro capsula. - essentielle hypertonie - synthetika

Canada - French - Health Canada

janssen inc - bortézomib (bortézomib, ester boronique de mannitol) - poudre pour solution - 3.5mg - bortézomib (bortézomib, ester boronique de mannitol) 3.5mg - antineoplastic agents

Canada - French - Health Canada

teva canada limited - bortézomib (bortézomib, ester boronique de mannitol) - poudre pour solution - 3.5mg - bortézomib (bortézomib, ester boronique de mannitol) 3.5mg - antineoplastic agents